Company CVAbout Shukra Pharmaceuticals Ltd 
Shukra Pharmaceuticals Ltd
Micro Cap
Pharmaceuticals & Drugs
Shukra Pharmaceuticals Limited (Formerly known Relish Pharmaceuticals Limited) was established in March, 1993 and later on the Company name was changed from Relish Pharmaceuticals Limited to Shukra Pharmaceuticals Limited effective on September 22, 2016. The Company is presently engaged in the business of manufacturing and trading of pharmaceuticals formulations and laboratory testing. The company provides varieties of products to the clientele.
Company Coordinates
Company Details
3 rd Floor Dev House, Opp WIAA Office Judges Bungalo Ahmedabad Gujarat : 380054
Registrar Details
Purva Shareregistry (India) Pvt Ltd , Gala No 9, Shiv Shakti, Industrial Estate,Sitaram Mill Comp., J R Boricha Marg, Lower Parel [E], Mumbai
Capital StructureCapital Structure
Present Equity Capital
INR 43.79 Cr
Number of Shares
43.79 Cr
Face Value
INR 1.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
21-Mar-2025
43.79
43.79
394091496
1
Stock Split
19-Apr-2024
4.38
43.79
32840958
10
Bonus Issue
12-Feb-2024
1.09
10.95
126265
10
Rights Partly Paid to Fully Paid Up
22-Sep-2023
1.08
10.82
9255046
10
Rights Partly Paid to Fully Paid Up
02-Feb-2023
1.1
10.96
9394050
10
Right Issues
31-Mar-2014
15.66
1.57
0
10
As Per Annual Report
10-Mar-2014
2.96
0.30
-11540302
10
Capital Reduction
10-Mar-2014
15.66
1.57
1270077
10
Amalgamation
10-Mar-2014
2.96
0.30
-11540302
10
Capital Reduction
10-Mar-2014
15.66
1.57
1270077
10
Amalgamation
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Promoters
Pledged Promoter Holdings
None
Mutual Funds
Held by 0 Schemes
FIIs
Held by 0 FIIs
Promoter with highest holding
Anar Project Private Limited (18.78%)
Highest Public shareholder
Yogesh Biharilal Parikh (19.18%)
Individual Investors Holdings
9.41%
Board of Directors
Management
Designation
Remuneration
Dakshesh Shah
Chairman & Managing Director
41.77 lacs
Payal Mehta
Executive Director
4.8 lacs
Bhoomiben Patel
Independent Director
0
Sarjeevan Singh
Independent Director
0
Sonal Deepalbhai Gandhi
Independent Director
0
Sanskruti Patel
Executive Director
0
Dhruvin Shah
Executive Director
0
Pinki Nirmal Sagar
Independent Director
0
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
No Data Available for Raw Material Segmentation
No Data Available
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Sales Commission
3.79
65.67%
Jobwork
0.75
13.07%
Sales Commission
Sales Commission
Jobwork
Jobwork
Stock DNARevenue and Profits:
Net Sales:
11 Cr
(Quarterly Results - Dec 2024)
Net Profit:
3 Cr
Pharmaceuticals & Drugs
INR 815 Cr (Micro Cap)
102.00
33
0.53%
-0.28
15.07%
15.32
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
